As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >


Laboratoiry R&D : 5 rue Henri Desbruères
91000 Evry-Courcouronnes

Head office : 3 boulevard de Sébastopol
75001 Paris

Email :

CEO : Maria Teresa Perez Zaballos
General Manager : Madeleine Moscatelli
Web Site >
EndoGene.Bio - Genopole's Company EndoGene.Bio - Genopole's Company

#Health #Diagnostics #Healthtech

  • Biotech
  • Femtech
  • Diagnostics
  • Endometriosis
  • Epigenetics

Field of Activity

Research & development for an in vitro diagnostic tool for endometriosis

EndoGene.Bio is the result of two women uniting their competencies: Maria Teresa Perez Zaballos, doctor in medical devices and ex portfolio expansion manager at Merck, and Madeleine Moscatelli, doctor in epigenetics. Their shared objective is to improve the management of women’s diseases. As a first mission, they are developing a method to diagnose endometriosis rapidly and efficaciously.

Description of the Products / Services / Technology
Despite affecting one woman in ten, it can take up to seven years to correctly identify endometriosis because of a lack of reliable and specific diagnostics. EndoGene.Bio seeks to change that by developing a diagnostic tool based on epigenetic biomarkers in menstrual blood samples that patients can take themselves in the comfort of their own homes.

Customer references / Collaborations / Highlights
EndoGene.Bio obtained a pre-seed investment from the start-up accelerator Entrepreneur First and has partnered with two hospitals to validate its proof of concept.
A seed funding campaign is also underway.

Collaborations Sought
Research laboratories, hospitals, pharmaceutical companies and biotechs developing treatments in the setting of endometriosis.

  • More informations

    Strengths: Advisory board including a KOL in endometriosis and experts in business development and women’s health; international hospital; dynamic, complementary and multidisciplinary team.

    Innovation assets: Developing a novel, disruptive approach to the diagnosis of endometriosis.


Genopole’s Companies


In same field

PEP-Therapy - Genopole's Company - logo 2021


PEP-Therapy develops innovative peptides as targeted therapies in oncology. The company operates a unique therapeutic technology based on cell penetrating & interfering peptides (CP&IP). These innovative molecules penetrate cells and specifically block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.

Exosome Analytics - Entreprise génopolitaine

Exosome Analytics

Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.



Platform for the bioproduction of RNA through fermentation in eukaryotic cells, a paradigm shift from in vitro synthesis

Kyron.Bio - Genopole's Company


Kyron.Bio is a biotech company using synthetic biology to produce new therapies with high yield, activity, and stability standards.

CGenetix - Entreprise génopolitaine


CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

Exosome Analytics - Entreprise génopolitaine

Exosome Analytics

Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.

Ciclix - StrokeHub - Genopole's company


Ciclix is a tech driven company specialized in process digitization for hospitals and focused on creating natural and efficient solutions for a variety of user profiles in the hospital environment.

Echoliv -Genopole's company


Echoliv is a MedTech startup that develops solutions based on artificial intelligence and applied to hepatic ultrasound. Our goal is to develop software to assist radiologists and hepatologists.

DeepTope - Genopole's company


– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodies

Theranovir - Genopole's Company


Biotechnology, R&D, Drug development, oncology, obesity, infectious diseases

Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Innovhem - Entreprise génopolitaine


Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Whitelab Genomics - Genopole's Company

WhiteLab Genomics

Artificial intelligence to optimize and accelerate the development of gene therapies

Traaser - Genopole's Company


Software for biomedical data analysis

Synsight - Genopole's Company


Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).

Sebia - Genopole's Company


Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.

Santen - Genopole's Company


Santen SAS has developed its own sales force to commercialize ophthalmic products in France while Novagali Innovation Center is a center of excellence for Santen Group dedicated to research and development of innovative ophthalmic treatments for all segments of the eye.

Pharnext - Genopole's company

Pharnext SA

Pharnext develops new therapies and biomarkers based on network pharmacology with a proprietary discovery platform. The company is focused on pathologies with high unmet medical needs. These include neurodegenerative, orphan and common diseases (Charcot-Marie-Tooth disease Type 1A, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS)).

IntegraGen - Genopole's Company


IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Généthon - Genopole's Laboratory


Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.

View all >
With the support from
Région île de France